Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants
Sponsor: Arcus Biosciences, Inc.
Summary
The purpose of this study is assess the safety and tolerability of AB102 and characterize the pharmacokinetics (PK) profile of AB102 after single and multiple ascending oral dose(s).
Official title: A Double-Blind, Randomized, Placebo-Controlled, Combined Single Ascending Dose and Multiple Ascending Dose First-In-Human Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AB102 in Healthy Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
130
Start Date
2026-07-09
Completion Date
2026-12
Last Updated
2026-08-25
Healthy Volunteers
Yes
Conditions
Interventions
AB102
Administered orally as specified in the treatment arm
Placebo
Administered orally as specified in the treatment arm
Locations (1)
Research Site
Groningen, Netherlands